LEADER 01482nas  2200541-a 450 
001 996212314403316
005 20231101152306.0
011   $a1474-5488
035   $a(OCoLC)45801855
035   $a(CKB)111006469465268
035   $a(CONSER)--2009233388
035   $a(DE-599)ZDB2035574-9
035   $a(EXLCZ)99111006469465268
100   $a20010126a20009999  s--            a
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 04$aThe Lancet oncology
210   $aAmsterdam ;$aNew York $cElsevier Science$d2000-
215   $a1 online resource
300   $aRefereed/Peer-reviewed
311   $a1470-2045 
531   $aLANCET ONCOLOGY
531   $aLANCET ONCOL
606   $aOncology$vPeriodicals
606   $aOncology$xPeriodicals
606   $aNeoplasms
606   $aNeoplasms$vPeriodicals
606   $aCancérologie$xPériodiques
606   $aCancérologie$vPériodiques
606   $aOncology$2fast$3(OCoLC)fst01045739
606   $aOncologie$2gtt
608   $aPeriodicals.$2fast
615  0$aOncology
615  0$aOncology$xPeriodicals.
615  2$aNeoplasms
615  2$aNeoplasms
615  6$aCancérologie$xPériodiques.
615  6$aCancérologie
615  7$aOncology.
615 17$aOncologie.
676   $a610.5
906   $aJOURNAL
912   $a996212314403316
996   $aThe Lancet oncology$91899279
997   $aUNISA